Summit Partners Public Asset Management’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-100,000
Closed -$19.9M 142
2025
Q3
$19.9M Sell
100,000
-30,000
-23% -$5.6M 0.65% 71
2025
Q2
$22.4M Buy
+130,000
New +$21.2M 0.87% 54
2025
Q1
Hold
0
155
2024
Q4
Sell
-55,101
Closed -$7.24M 161
2024
Q3
$8.23M Sell
55,101
-178,572
-76% -$24.1M 0.37% 82
2024
Q2
$31.9M Buy
233,673
+8,562
+4% +$1.16M 1.47% 31
2024
Q1
$34M Buy
+225,111
New +$32.1M 1.63% 29
2023
Q2
Sell
-169,693
Closed -$18.2M 137
2023
Q1
$18.2M Sell
169,693
-3,058
-2% -$350K 1.02% 51
2022
Q4
$21.1M Buy
+172,751
New +$20.1M 1.54% 32
2022
Q2
Sell
-58,651
Closed -$6.88M 149
2022
Q1
$6.88M Buy
+58,651
New +$6.79M 0.38% 86

Other funds holding ASND